Biotech-stock investing has one tough test for success - and it's about to get easier ...

A breakthrough at the Lagos University Teaching Hospital, Idi-Araba, has brought cheery news to people with sickle cell ...

Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.

Skorney cited a drug called Oxbryta from Pfizer (PFE), which was approved to treat the blood disorder sickle cell. Instead of using clinical ... and difficulties with speech. The disease is so rare, ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...